This inventor holds 2 USPTO granted patents and 19 published patent applications. Top assignees: Ampel Biosolutions, LLC, Ampel, LLC. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Amrie C Grammer: Innovator in Machine Learning and Genomic Analysis
Introduction
Amrie C Grammer is a notable inventor based in Charlottesville, VA, who has made significant contributions to the field of machine learning and genomic analysis. His work focuses on the intersection of technology and healthcare, particularly in understanding complex diseases such as lupus and cardiovascular disease.
Latest Patents
Grammer holds a patent titled "Methods and systems for machine learning analysis of single nucleotide polymorphisms in lupus." This patent outlines innovative systems and methods for machine learning classification and assessment of disease based on gene expression data. The method involves assaying a biological sample to produce a data set of gene expression measurements at various disease-associated genomic loci. The data is then processed to determine the disease state of the subject, ultimately providing an electronically outputted report indicative of the subject's health status.
Career Highlights
Amrie C Grammer is associated with Ampel Biosolutions, LLC, where he applies his expertise in machine learning and genomics to develop solutions for disease assessment. His work is pivotal in advancing the understanding of genetic factors in diseases, which can lead to improved diagnostic methods and treatment options.
Collaborations
Grammer has collaborated with esteemed colleagues such as Peter E Lipsky and Katherine A Owen, contributing to a rich environment of innovation and research in the field of genomics and machine learning.
Conclusion
Amrie C Grammer's contributions to machine learning and genomic analysis exemplify the potential of technology to transform healthcare. His innovative approaches are paving the way for better understanding and management of complex diseases.